CGRP Inhibitors and Oxidative Stress Biomarkers in Resistant Migraine: A Real-Life Study with Erenumab, Fremanezumab, and Galcanezumab
暂无分享,去创建一个
S. Gori | M. Papa | G. Siciliano | F. Baldacci | S. Mazzucchi | L. Chico | C. De Luca | M. Ulivi | I. Lombardo | Letizia Curto
[1] M. Nowaczewska,et al. Changes in Cerebral Blood Flow after Erenumab Treatment in Good and Non-Responders—A Pilot Study of Migraine Patients , 2021, Journal of clinical medicine.
[2] E. Bellei,et al. Urinary Proteomics Reveals Promising Biomarkers in Menstrually Related and Post-Menopause Migraine , 2021, Journal of clinical medicine.
[3] S. Sacco,et al. Social Distancing in Chronic Migraine during the COVID-19 Outbreak: Results from a Multicenter Observational Study , 2021, Nutrients.
[4] Miguel A. Miranda,et al. Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance , 2021, The Journal of Headache and Pain.
[5] E. Caronna,et al. Update on Calcitonin Gene-Related Peptide Antagonism in the Treatment of Migraine. , 2021, Neurologic clinics.
[6] S. Gori,et al. Supersaturation of VEP in Migraine without Aura Patients Treated with Topiramate: An Anatomo-Functional Biomarker of the Disease , 2021, Journal of clinical medicine.
[7] M. Zaletel,et al. Enhanced Hemodynamic and Clinical Response to αCGRP in Migraine Patients—A TCD Study , 2021, Frontiers in Neurology.
[8] F. Brighina,et al. Migraine and Sport in a Physically Active Population of Students: Results of a Cross‐Sectional Study , 2020, Headache.
[9] Eun Sug Park,et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.
[10] S. Sacco,et al. European headache federation consensus on the definition of resistant and refractory migraine , 2020, The Journal of Headache and Pain.
[11] C. D. Luca,et al. The fifth cranial nerve in headaches , 2020, The Journal of Headache and Pain.
[12] Sorana D. Bolboacă,et al. Retinal Nerve Fiber Layer Thickness and Oxidative Stress Parameters in Migraine Patients without Aura: A Pilot Study , 2020, Antioxidants.
[13] Lei Yang,et al. Calcitonin gene‐related peptide inhibits angiotensin II‐induced NADPH oxidase‐dependent ROS via the Src/STAT3 signalling pathway , 2020, Journal of cellular and molecular medicine.
[14] P. Ao,et al. CGRP Reduces Apoptosis of DRG Cells Induced by High-Glucose Oxidative Stress Injury through PI3K/AKT Induction of Heme Oxygenase-1 and Nrf-2 Expression , 2019, Oxidative medicine and cellular longevity.
[15] J. Schoenen,et al. The metabolic face of migraine — from pathophysiology to treatment , 2019, Nature Reviews Neurology.
[16] S. Gori,et al. Plasma Levels of Oxidative Stress Markers, before and after BoNT/A Treatment, in Chronic Migraine , 2019, Toxins.
[17] F. Guadagni,et al. Circulating Biomarkers In Migraine. New Opportunities For Precision Medicine. , 2019, Current medicinal chemistry.
[18] S. Taysı,et al. Oxidative stress and DNA damage in patients with migraine , 2016, The Journal of Headache and Pain.
[19] S. Gori,et al. Evidences of Reduced Antioxidant Activity in Patients With Chronic Migraine and Medication‐Overuse Headache , 2015, Headache.
[20] P. Martínez-Camblor,et al. OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine , 2015, Pain.
[21] S. Silberstein,et al. Episodic and Chronic Migraine Headache: Breaking Down Barriers to Optimal Treatment and Prevention , 2015, Headache.
[22] M. Aguggia. Allodynia and migraine , 2012, Neurological Sciences.
[23] L. Edvinsson. Role of CGRP in Migraine. , 2019, Handbook of experimental pharmacology.
[24] M. Arnold. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition , 2018, Cephalalgia : an international journal of headache.
[25] S. Benemei,et al. The TRPA1 channel in inflammatory and neuropathic pain and migraine. , 2014, Reviews of physiology, biochemistry and pharmacology.